Cahill Gordon & Reindel LLP
32 Old Slip
New York, NY 10005
Beth is a partner in Cahill Gordon & Reindel LLP’s corporate practice group, with a particular focus on capital markets and lending. Beth represents leading investment banks and commercial banks in connection with syndicated loan transactions, asset-based lending transactions, bridge lending, and public and private capital markets transactions, including offerings of secured and unsecured debt securities, equity offerings, debt exchange offers, tender offers and consent solicitations in connection with acquisition financings, leveraged buyouts, going-private transactions, recapitalizations, project financings, out-of-court restructurings and other financing transactions. She has represented the financing sources in a number of acquisitions and investments, including Kissner Group’s acquisition of Morton Salt, Jazz Pharmaceuticals’ acquisition of GW Pharmaceuticals, and Stone Point Capital’s acquisition of Corelogic. She has also represented public corporations, including ICON plc in connection with financing its acquisition of PRA Health Sciences, Inc.
In 2023, Beth was recognized as a Structured Finance Rising Star by Law360. In 2022, she was profiled in The Secured Lender’s Women in Secured Finance issue. She has previously been recognized among Best Lawyers’ “Ones to Watch” in the areas of banking and finance law and corporate law.